Dr Pamela Minicozzi

Assistant Professor

Keppel Street
United Kingdom

Dr Pamela Minicozzi graduated in Applied Mathematics from the University of Pavia (Italy) in 2006, then completed a Master in Medical Statistics and Statistical Methods for Epidemiology at the University of Milan (Italy) in 2009, followed by a PhD in Public Health and Educational Science in 2012 at the University of Pavia (Italy), and a Master in Business Intelligence and Big Data Analytics at the University of Milan-Bicocca in 2018.

She was a Research Fellow in the Molecular Ecotossicology Unit, Department of Environmental Science and Life in Alessandria (Italy) in 2007. From 2007 to 2019, she worked as a Research Fellow in the Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan (Italy), on EUROCARE (European Cancer Registry-based study of survival and care of cancer patients) and related studies, like among others the European High Resolution Studies on inequalities in survival from breast, colorectal, and lung cancers, skin melanoma and haematological malignancies. She has been working in the Cancer Survival Group at LSHTM since August 2019.


Faculty of Epidemiology and Population Health
Department of Non-communicable Disease Epidemiology


Pamela teaches on the Basic Epidemiology module in Term 1, and the Statistical Methods for Epidemiology (SME) and Survival Analysis modules in Term 2. She is also involved in the supervision of the Distance Learning MSc Epidemiology Projects.


She is currently working on the CONCORD programme, focused on the international comparisons of cancer survival, and on the VENUSCANCER project, analysing more in deep the inequalities in survival from cancers of the breast, cervix and ovary.

Research Area
Health inequalities
Public health
Statistical methods
Disease and Health Conditions

Selected Publications

Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD-3 study.
Nikšić M; Minicozzi P; Weir HK; Zimmerman H; Schymura MJ; Rees JR; Coleman MP; Allemani C; US CONCORD Working Group
Cancer communications (London, England)
Association of Sentinel Node Biopsy and Pathological Report Completeness with Survival Benefit for Cutaneous Melanoma and Factors Influencing Their Different Uses in European Populations.
Sant M; Magri MC; Maurichi A; Lillini R; Bento MJ; Ardanaz E; Guevara M; Innos K; Marcos-Gragera R; Rubio-Casadevall J
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries.
Ssenyonga N; Stiller C; Nakata K; Shalkow J; Redmond S; Bulliard J-L; Girardi F; Fowler C; Marcos-Gragera R; Bonaventure A
The Lancet Child & Adolescent Health
Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials.
Vener C; Rossi S; Minicozzi P; Marcos-Gragera R; Poirel HA; Maynadié M; Troussard X; Pravettoni G; De Angelis R; Sant M
Frontiers in Oncology
Is short-term survival from metastatic cutaneous melanoma improving? Results from 22 countries (CONCORD-3).
Di Carlo V; Matz M; Minicozzi P; Ssenyonga N; Coleman M; Allemani C
The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study.
Henderson RH; French D; Maughan T; Adams R; Allemani C; Minicozzi P; Coleman MP; McFerran E; Sullivan R; Lawler M
The lancet. Gastroenterology & hepatology
World-wide trends in survival for children, adolescents and young adults (0-24 years) diagnosed with leukaemia during 2000-2014 in 61 countries (CONCORD-3).
Ssenyonga N; Di Carlo V; Girardi F; Matz M; Minicozzi P; Coleman M; Allemani C
Olfactory signals and fertility in olive baboons.
Vaglio S; Minicozzi P; Kessler SE; Walker D; Setchell JM
Scientific reports
See more Publications